A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer.
Ward, S;
Morris, E;
Bansback, N;
Calvert, N;
Crellin, A;
Forman, D;
Larvin, M;
Radstone, D;
(2001)
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer.
Health technology assessment (Winchester, England), 5 (24).
pp. 1-70.
ISSN 1366-5278
DOI: https://doi.org/10.3310/hta5240
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.